|
2024
|
Invention
|
Treatment and prevention of pre-eclampsia.
The present invention relates to the field of medicin... |
|
2023
|
G/S
|
Pharmaceutical preparations and substances for the treatment of viral diseases and disorders name... |
|
|
G/S
|
Pharmaceutical preparations. |
|
2022
|
G/S
|
Medical testing for diagnostic or treatment purposes |
|
|
G/S
|
Medical testing. |
|
|
Invention
|
Using c1 esterase inhibitor to treat viral infection-related symptoms.
The claimed invention rel... |
|
|
Invention
|
Using c1 esterase inhibitor to treat viral infection-related symptoms. The claimed invention rela... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of immune system related diseases and disorders nam... |
|
|
G/S
|
Pharmaceutical preparations containing phosphatidylinositol 3-kinase inhibitors for the treatment... |
|
2021
|
Invention
|
Using c1 esterase inhibitor to treat viral infection-related acute respiratory distress.
The cla... |
|
|
Invention
|
Using c1 esterase inhibitor to treat viral infection-related acute respiratory distress. The clai... |
|
2020
|
G/S
|
pharmaceutical preparations for the treatment of immune system related diseases and disorders |
|
|
G/S
|
Pharmaceutical products. |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of viral diseases and disorders nam... |
|
2019
|
Invention
|
Pharmaceutical system for transdermal administration of a c1 -esterase inhibitor. The present inv... |
|
|
Invention
|
Treatment and prevention of pre-eclampsia. The present invention relates to the field of medicine... |
|
2018
|
G/S
|
Pharmaceutical products for the treatment of hereditary angioedema, also referred to as HAE. |
|
2017
|
G/S
|
Pharmaceutical preparations and substances for the treatment of viral, [ metabolic, endocrine, mu... |
|
|
G/S
|
pharmaceutical products for the treatment of hereditary angioedema, also referred to as HAE |
|
2016
|
G/S
|
Pharmaceutical products. Retail and wholesale services in the field of pharmaceutical products. S... |
|
2013
|
Invention
|
Use of c1 inhibitor for the prevention of ischemia-reperfusion injury. The present invention rela... |
|
2012
|
Invention
|
Milking device. A milking device includes a vessel and cover plate. The vessel and the cover plat... |
|
|
Invention
|
Milking device. A milking device includes a vessel (2) and cover plate (3). The vessel and the co... |
|
2011
|
Invention
|
Use of anticoagulants in the production of recombinant proteins in the milk of transgenic animals... |
|
|
G/S
|
Pharmaceutical products for the treatment of hereditary angioedema (HAE). |
|
2009
|
Invention
|
Treatment of bleeding with low half-life fibrinogen. The invention provides low-half life fibrino... |
|
2007
|
Invention
|
Fibrinogen from transgenic animals.
The present invention provides a method for the part purific... |
|
|
Invention
|
C1 inhibitor with short half-life transient treatment. The present invention relates to the use o... |
|
2005
|
Invention
|
C1 inhibitor produced in the milk of transgenic mammals.
The invention provides transgenic nonhu... |
|
2004
|
Invention
|
C1 inhibitor with short half-life for transient treatment. The present invention relates to the u... |
|
|
Invention
|
Dna sequences to target proteins to the mammary gland for efficient secretion. Described is a met... |
|
|
Invention
|
Expression of proteins in milk. This invention relates to the production of recombinant proteins ... |
|
2003
|
Invention
|
Protein modification.
The present invention relates to a method for changing the half-life of a ... |
|
|
Invention
|
Protein modification. The present invention relates to a method for changing the half-life of a g... |
|
2002
|
Invention
|
Peptide production. A method of producing a substance comprising a peptide, involves incorporatin... |
|
|
Invention
|
C1 inhibitor produced in the milk of transgenic non-human mammals. The invention provides transge... |
|
|
Invention
|
Methods for cloning mammals using remodeling factors.
Methods and compositions are provided for ... |
|
|
Invention
|
Production of recombinant polypeptides by bovine species and transgenic methods. Transgenes for p... |
|
|
Invention
|
Sex- specific selection of sperm from transgenic animals.
The present invention relates to metho... |
|
2001
|
Invention
|
Fusion proteins incorporating lysozyme. A process for the production of a peptide is disclosed, t... |
|
|
Invention
|
Stabilization of milk from transgenic animals. 1-antitrypsin) in the milk of the transgenic animals. |
|
|
Invention
|
High dosage parenteral administration of lactoferrin. The invention provides methods of treatment... |
|
|
Invention
|
C1 inhibitor produced in the milk of transgenic mammals. The invention provides transgenic nonhum... |
|
2000
|
Invention
|
Purification of alpha-1 proteinase inhibitor. A method for purifying human or other alpha-l prote... |
|
1999
|
Invention
|
Expression methods. The present invention relates to human bile salt-stimulated lipase (BSSL) obt... |
|
|
Invention
|
Method of producing a polypeptide in an ungulate. The present invention relates to cloning techno... |
|
|
G/S
|
Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use... |
|
1998
|
Invention
|
Useful properties of human lactoferrin and variants thereof. The invention provides compositions ... |
|
1997
|
Invention
|
Production of heterologous protein in milk of transgenic non-human mammals comprising a construct... |
